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ABSTRACT
Cervical cancer is a prominent cancer in U.S. women caused primarily by the human
papilloma virus and its incidence and mortality rates have decreased through screening programs.
Certain barriers are perceived to be affecting the rates of cervical cancer screening among women
living with HIV (WLWH). A systematic review was conducted to identify and summarize these
barriers among WLWH nationwide. There is a need to increase awareness and education among
WLWH. Public health programs and community-based interventions should target women of low
SES and minority status while assessing the barriers among this population to improve cervical
cancer screening rates.
Keywords: Cervical cancer; Cancer Screening; Women living with HIV; HPV positive
women
INTRODUCTION
Cervical cancer is one of the most prominent gynecological cancers ranking 14th in
frequency in the USA (National Institutes of Health, 2010). In 2014, 12,578 women were
diagnosed with cervical cancer and 4,115 women died from cervical cancer in the USA (U.S.
Cancer Statistics, 2014). The age-adjusted incidence rates, per 100,000 women, for HPVassociated cervical cancer in the USA during the years 1998-2012, was highest among Hispanics
(9.7) compared to Non-Hispanics (7.1), The rates were higher in African-Americans (9.2) followed
by Whites (7.1), American Indians/Alaskan Natives (6.3), and Asian/Pacific Islanders (6.1) (Viens
et al., 2016).
Of the gynecologic cancers (cervical, ovarian, uterine, vaginal, and vulvar), only cervical
cancer has a screening test. The screening tests include the Pap (Papanicolaou) test and human
papillomavirus (HPV) test, as most cases are caused by HPV (Baseman & Koutsky, 2005). In a
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Pap test, the sample is examined to see if the cells are atypical presenting with low-grade squamous
intra-epithelial neoplasia [LGSIL], high-grade squamous intra-epithelial neoplasia [HGSIL] or
atypical squamous cells of undetermined significance (ASCUS). The HPV sample is tested for the
presence of 13–14 of the most common high-risk HPV types because cervical cancers associated
with certain HPV types were considered to be of high risk (Musa et al., 2005). The screening tests
can detect the cancer during early stages where the treatment can be most effective. Current
American College of Obstetricians and Gynecologists (ACOG) guidelines recommend women
ages 21–29 years should have a Pap test every 3 years. Women ages 30–65 years should have a
Pap test and an HPV test (co-testing) once every 5 years, or only the Pap test once every 3 years
(Practice Bulletin, ACOG, 2016). However, in WLWH and those with prior history of cervical
cancer, the ACOG states that they may require more frequent cervical cancer screening and
recommends they do not follow the routine guidelines (ACOG, n.d.).
Cervical Cancer in WLWH
Women living with HIV (WLWH) are at increased risk of getting HPV infection compared
with the general adult female population (Clofford et al., 2005; Grulich et al., 2007; Bratcher and
Sahasrabuddhe, 2010). The Canadian Women's HIV Study shows that the crude prevalence rates
of HPV infection among WLWH was 73.6% as compared to 52.5% among WLWH (Hankins et
al., 2000). Another study showed that women with AIDS-defining illness or with low level of
immunity (with CD4+ T cell count <200 cells/mm3) have a six-fold increase of abnormal cytology
of the cervix (Maiman et al., 1998). WLWH show a seven-fold increase of HPV infection
compared to women without HIV infection (Womack et al., 2000). HPV types 16 and 18 are of
higher oncogenic risk than the other types. WLWH are more likely to be infected with these highrisk HPV types and are also infected with multiple HPV types than the women without HIV
infection (Sun et al., 1997). Highly Active Anti-Retroviral Therapy (HAART) has increased the
lifespan of WLWH; yet there is a prolonged risk of exposure to HPV putting them at higher risk
for cervical cancer.
Additionally, the United States Food and Drug Administration has approved three vaccines
for prevention of HPV infections (Gardasil, Gardasil 9 and Cervarix) for girls aged 11-12 years
and can be given up to the age of 26 years (Gillison et al., 2008). The current vaccines provide
strong protection against new HPV infections for certain types of viral strains, but they are not
effective at treating established HPV infections or disease caused by HPV (Hildesheim et al.,
2007). However, in WLWH, these vaccines are less robust in increasing an immune response
(Levin et al., 2010). The HPV infection in individuals living with HIV is caused by certain strains
of the HIV virus which are not covered by the vaccine (Heard, 2009). Therefore, it is highly
recommended that WLWH adhere to a regular screening schedule for the early detection of
cervical cancer.
New guidelines were effective from 2012 as recommended by U.S. Preventive Services
Task Force (USPSTF) for cervical cancer screening. As per the new guidelines, WLWH are
recommended to have screening every 6 months in the first year of HIV diagnosis and annually
thereafter (Moyer and U.S. Preventive Services Task Force, 2012). There are several barriers and
factors influencing cervical cancer screening rates among general population such as older age,
lower income, education level, lack of health insurance, unmarried status etc. (Datta et al., 2006).
Several other risk factors influence cervical cancer screening rates in WLWH such as age,
race/ethnicity, lower income, lack of health insurance, not having a regular source of primary
health care, high viral loads, low CD4+ T cell counts, cigarette smoking and injection drug use.
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(Baranoski et al., 2011; Chen et al., 2012; Lambert et al., 2015). The objective of this study is to
assess and summarize the barriers and/or risk factors influencing cervical cancer screening rates
among WLWH of the USA through a systematic review since the implementation of new
guidelines in 2012. To our knowledge, there has been no systematic review conducted specifically
among this sub-group.
METHODS
Search Strategy
A systematic literature review was conducted to summarize the barriers and/or risk factors
of cervical cancer screening rates among WLWH in the USA and therefore IRB approval was
unnecessary for this study. The databases PubMed and Cochrane Library were searched for peerreviewed journal articles published between January 1, 2012 and October 31, 2017.
Inclusion Criteria
Qualitative and quantitative studies that identify the barriers or factors influencing cervical
cancer screening rates at the health service level or at a community level in WLWH are included
in the systematic review. The literature search was restricted to peer-reviewed articles that are
published in the English language that demonstrated the risk factors for receiving cervical cancer
screening rates in WLWH. This review considered the studies limited to the USA where there are
standard guidelines for cervical cancer screening.
Exclusion Criteria
Conference abstracts and unpublished manuscripts were excluded from this review due to
difficulty in obtaining these documents or unclear demonstration of the barriers discussed above.
Studies conducted outside of the USA, which may follow different guidelines, and articles
published in a language other than English were excluded from this review. Finally, any previous
systematic reviews identifying the barriers were also excluded from this review.
Search Terms
The search terms or key words chosen for searching the databases are (“HIV-positive
women” or “HIV-positive females” or “HIV-infected women” or “HIV-infected females”) and
(“cervical cancer screening” or “Pap smear test” or “Pap test” or “human papilloma virus test” or
“HPV test”) and (“barriers” or “risk factors”).
Retrieval of Studies
The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)
guidelines were followed in selection of the eligible articles, appraisal and during the synthesis of
the results (Boland et al., 2014). An initial search across the PubMed and Cochrane databases was
conducted and these citations were exported into Mendeley software and assessed for duplicates.
The imported citations were then title screened and abstract screened considering the inclusion
criteria. Full text articles of the included studies were reviewed for final eligibility of the studies.
Two independent researchers completed the title screening, abstract assessment, full texts, and for
assessment of eligibility.
The Critical Appraisal Skills Programme (CASP) (2017a, 2017b) checklist was used for
methodological assessment of the studies. The risk of bias for each included study was assessed
using the Newcastle-Ottawa Scale (NOS) for non-randomized studies (Wells et al., 2013). Finally,
a narrative synthesis of the eligible studies which have significant quality was done to know the
effective barriers for cervical cancer screening in WLWH.
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RESULTS
Literature Search
An initial search across the databases using the search terms yielded a total of 253 citations.
After assessing for duplications, there were a total of 251 studies for title screening and abstract
screening. Twenty-one articles were extracted after applying the inclusion and exclusion criteria
defined above. Full text articles for the 21 studies were assessed again with the selection criteria
for eligibility. Three articles were excluded at this point: two studies were conducted outside of
the USA and the third one was not relevant to the aims/objectives of the systematic review.
Eighteen articles were included in the qualitative synthesis, where one article was excluded
because of non-relevancy to the aims of the systematic review. Seventeen articles were eligible
and included in this systematic review for synthesis (Table 1). The entire process was represented
in Figure 1 using the PRISMA flow diagram (Moher et al., 2009).

The objectives, study design, study setting, outcomes, and results were examined in all
eligible articles. Thirteen of the eligible studies are either retrospective or prospective cohort
studies (Castle et al., 2012; Curry et al., 2012; Setse et al., 2012; Alade et al., 2017; Kim et al.,
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2013; Fletcher et al., 2014a, 2014b; Simonsen et al., 2014; Lofgren, 2015; Ogunwale et al., 2016;
Aserlind et al., 2017; Lakshmi et al., 2017; Levinson et al., 2017). Cross et al (2014) is an
interventional study; Frazier et al Hessol et al & Lambert et al are cross-sectional studies (Hessol
et al., 2013; Lamert et al., 2015; Frazier et al., 2016). All of these studies were conducted either in
a hospital or clinical setting which provides comprehensive clinical care for WLWH (Table 1).
Table 1: Characteristics of the Included Studies:
Study
Objective
Study
Sample size /
Design/
Participants
Setting

Outcomes

Results

WLWH with
concurrent
normal
cervical
cytology has
low 3- year
risk of
developing
CIN+2
lesions, with
adequate HIV
treatment and
low levels of
CD4
Utility of
cervical
cancer
screening in
WLWH over
the age of 65
is described,
with 48% of
them who
required
colposcopies
based on Pap
tests didn’t
have it.

Alade,
2017

WLWH with
concurrent
normal
cervical
cytology and
undetectable
cervical HPV
has low risk
of
developing
CIN

Retrospective
cohort, chart
review/
Clinical setting

325 / WLWH
aged 30 years
and above

20% has
detectable HPV,
cumulative CIN+2
diagnosis for
HPV-negative
cohort was 1.4%,
vs 14.5% for
HPV-positive
cohort

Aserlind,
2017

Cervical
cancer
screening
practices
before the
new
guidelines in
WLWH,
description
of
comorbidities
and risk
factors

Retrospective
cohort, chart
review/
Clinical setting

75 / WLWH
aged 65 years
and above

Castle,
2012

Assessing the
risk of
cervical
precancer

Retrospective
cohort,
Electronic

245 / WLWH
aged 30 years
and above

85% of the tested
women has
ASCUS out of
which 14%
progressed to
LSIL and only one
progressed to
HSIL. 69% are
AfricanAmericans and
80% below the
federal poverty
line
Comorbidities,
STIs, risk factors
evaluated
Repeated cotesting was carried
in 12-month
intervals. After

Those
WLWH with
negative
contesting
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and cancer
after negative
co-testing
(Pap test and
HPV test) in
WLWH

Medical
Records/
Clinical setting

second co-test,
236 WLWH
showed no cases
of CIN2+ and
after third co-test
with remained 78
women, no cases
of CIN2+ were
reported.

Cross,
2014

Identify
factors for
inadequate
screening
and analyze
the
interventions
for
increasing
screening
rates

Pre-Post
Interventional
study design/
Clinical setting

422 / WLWH

WLWH has a
mean of 4.2 visits
who received
screening vs 3.4
visits who did not
receive screening
tests, in one-year
time-period
p < 0.01).

Curry,
2012

Assess the
rates of
CIN2+ with
minimally
abnormal
Pap tests in
WLWH and
disease-free
women

Retrospective
cohort/
Clinical setting

655 / WLWH
and diseasefree women

WLWH were
twice as likely to
be diagnosed with
CIN2 + after a
minimally
abnormal Pap test
than HIVuninfected
women

Fletcher
&
Buchberg,
2014

Describe the
barriers and
facilitators
for screening
services in
WLWH

Prospective
Qualitative
approach using
focus groups/
Integrated HIV
clinic

33 / WLWH
aged 18 years
and older

Barriers and
facilitators for
screening services
were evaluated
from focus group
questionnaire

conferred
safety against
cervical
precancer and
cancer
progression,
provided CD4
cell counts
and HIV-viral
loads are
checked at
regular
intervals.
WLWH with
more clinical
visits per year
and Prior
atypical
cervical
cytology were
more likely to
receive
cervical
cancer
screening
tests.
WLWH have
higher rates of
underlying
CIN2 + for
minimally
abnormal Pap
tests
compared
with diseasefree women
Barriers
include pain
and
discomfort
associated
with testing,
lack of
awareness,
lack of
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Fletcher
&
Vidrine,
2014

Identify the
factors for
nonadherence to
screening in
WLWH
smokers

Retrospective
cohort, data
collected from
electronic
medical
records and
secondary data/
HIV clinic

138 / WLWH
smokers

African American
women were four
times more likely
than white women
to be non-adherent
to Pap screening

Frazier,
2016

To know the
prevalence of
cervical
cancer and
factors
associated
with Pap
tests in
WLWH
Assess the
factors
associated
with HPV
infections in
WLWH and
high-risk
women

Cross-sectional
study, using
interview and
medical
records data /
HIV clinic with
Medical
Monitoring
Project(MMP)
CrossSectional
Study, nested
from Women’s
Interagency
HIV Study
(WIHS) /
Women’s
Interagency
HIV Study
(WIHS) from
six centers in
the US

2270 / WLWH

Assess the
long-term
effect of
HAART and
menopause
on SILs in
WLWH

Retrospective
cohort,
databases
reviewed /
Hospital bases
AIDS center

313 / Only 245
WLWH were
eligible

Factors which
made less likely to
report Pap tests
are older age
groups, income
above FPL and
those with no
sexual activity in
the last 12 months
42% of HPW had
detectable cervical
HPV infection vs
8% on disease free
women, WLWH
were more likely
to have
concomitant HPV
infection with
more than one
HPV type
compared with
disease free
women
Menopausal
women had a 70%
higher risk of
progression
to SILs than
premenopausal
women, HAART

Hessol,
2013

Kim, 2013

655 / 470
WLWH and
185 disease
free women

transportation,
scheduling
appointments
Factors for
nonadherence to
screening
among HPW
smokers are
younger age,
AfricanAmerican
race, rigorous
drinking, and
smoking
habits
Suggests
integration of
HIV-care
services with
OBGYN
services to
improve
screening
rates in HPW
Factors are
higher mean
years of
smoking
cigarettes,
WLWH,
especially
with low CD4
counts should
be screened
for cervical
cancer

Increased
CD4 increases
risk of
lesions;
younger and
menopausal
increases risk
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Lakshmi,
2017

Assess how
frequent
infectious
disease (ID)
physicians
provide
primary care
for HPW and
assess their
barriers for
providing
primary care.

Prospective
Cohort /
Survey based
from Emerging
Infections
Network

644 / Survey
from only 326
Primary care
Physicians
treating
WLWH was
assessed

Lambert,
2015

Assess
relationships
between Pap
test
adherence
and
constructs
of the Health
Belief Model
(HBM)

cross-sectional,
quantitative
correlational
design / Two
ambulatory
care clinics

300 / WLWH
aged 18 years
and above

Levinson,
2017

Evaluating
gynecologic
cancer
treatments in
HPW for
adherence to
guidelines
and compare
the survival

Retrospective
cohort study,
Chart reviews /
Two
Comprehensive
care centers

57 / WLWH

had a 52%
reduced risk in the
progression to
SILs compared to
women
receiving any
other antiretroviral
regimen
Barriers reported
include: refusal by
patient (72%),
non-adherence to
HIV medications
(43%), other
health priorities
(44%), time
constraints during
clinic visit (43%)
and
financial/insurance
limitations (40%).
WLWH perceived
lower personal
risk for cervical
cancer, those with
higher perceived
self-efficacy and
lower
perceived barrier
scores received
better Pap test
adherence.
48-month survival
was higher in
HPW who
received adherent
care (60%) than
those who did not
(28%).

and being on
HAART
decreases risk
of progression
of lesions.

Most ID
physicians act
as primary
care
providers for
their HIV
infected
patients, but
screening
rates were
suboptimal

WLWH were
not aware of
the risk for
cervical
cancer
And the
preventive
actions

Those who
did not
receive
adherent care
had worse
survival
compared to
those who
did, 69% were
due to patientrelated
barriers.
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Lofgren,
2015

Evaluate the
progression
and
regression of
cervical
dysplasia in
HPW and
associated
factors for
pap tests

Ogunwale, To evaluate
factors
2016
impacting the
prevalence of
cervical
cancer
screening
among HPW

Setse,
2012

To evaluate
factors
impacting the
prevalence of
cervical
cancer
screening
among
adolescent
HPW

Retrospective
Cohort /
Clinical setting

309 / WLWH

Prospective
cohort, selfadministered
questionnaire /
HIV integrated
clinic

179 / WLWH
aged between
21 and 64
years

Prospective
Cohort, chart
review /
Longitudinal
Epidemiologic
Study to Gain
Insight into
HIV/AIDS in
Children and
Youth
(LEGACY)
cohort
participants
from 22 clinics
in US

231 / WLWH
aged 13-24
years of age

31% reported
regression of
lesions and 24%
reported
progression of
lesions. Those on
anti-retroviral
therapy (ART)
regressed by
12.5% than those
who are not on
ART (0%)
Knowledge of
cervical cancer
risk factors, such
as multiple sexual
partners or
sex with a man
with multiple
partners, was low

Prevalence of
cervical cancer
screening was low
there is abnormal
cytology in about
50% and
associated risk
factors

Initial CD4
counts above
200 cells/
mL was
associated
with
regression or
remaining
normal.

Unscreened
women
were younger
and more
likely to be
single with
multiple
current sexual
partners,
knowledge of
cervical
cancer risk
factors among
low-income
groups
influence
screening
rates
Decreased
screening was
seen among
perinatal HIV
infection and
AfricanAmerican
race.
Increased
rates in HPW
diagnosed
with STIs,
previous
STIs, CD4
counts <200
cells/ul
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To evaluate
Retrospective
192 / WLWH
Documentation of HPW with
preventive
Cohort Study,
cervical cancer
private
health care
Medical record
screening is low,
insurance
services
reviews /
57% only
were less
(cervical
Infectious
likely to have
cancer
Disease Clinic
cervical
screening
cancer
included) in
screening
HPW and its
(P=0.025)
associated
factors
*Note: Abbreviations: Women living with HIV (WLWH), atypical squamous cells of undetermined significance
(ASCUS), low-grade squamous intraepithelial neoplasia (LSIL), high-grade squamous intraepithelial neoplasia
(HSIL), cervical biopsies read as grades 1, 2, or 3 Cervical Intraepithelial Neoplasia (CIN), Highly Active AntiRetroviral Therapy (HAART), Squamous Intraepithelial Lesions (SIL), Sexually Transmitted Infections (STI)
** The terms, “women living with HIV” or “WLWH” were not used at the time of the initial search query as this
preferred verbiage was more widely established subsequent to the search.

Simonsen,
2014

Barriers or Factors that affect Cervical Cancer Screening Rates among WLWH from Eligible
Studies
Several barriers were identified in multiple studies which included: low income, lack of
insurance, lower screening rates in specific populations, age groups, higher HIV viral loads, lower
CD4+ T cell counts, lack of adherence, lack of awareness, limited transportation, pain and
discomfort associated with pap smear testing, number of health visits, issues related to making an
appointment, provider specific barriers, and other factors.
Lower Income
It was stated that forty eight percent of the WLWH did not attend follow up visits or the
subsequent screening visits because the majority of those women (~ 80%) were below the federal
poverty line (Aserlind et al., 2017). However, the underlying factors surrounding poverty as a
barrier were not addressed; for example, lack of either transportation or a sliding fee scaled based
on income.
Lack of Insurance
WLWH with financial and insurance limitations had low cervical cancer screening rates
(Simonsen et al., 2014; Lakshmi et al., 2018).
Lower screening rates in African Americans
The African-American group of WLWH were four times non-adherent to cervical cancer
screening than Caucasian women (Fletcher et al., 2014b). The factors reported which contribute
to such low screening are caregiving responsibilities, lack of housing stabilities, lack of financial
stabilities, stigma associated with the cervical cancer screening procedures and non-disclosure.
Older Age Group
WLWH who are of older age groups, were less likely to report to the screening services
(Kim et al., 2013; Frazier et al., 2016).
Higher HIV Viral Loads
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WLWH who had higher viral loads had fewer follow up visits to regular and gynecological
care services, thereby having lower screening rates than those with lower or undetectable HIV
viral loads (Castle et al., 2012).
Lower CD4+ T Cell Counts
WLWH with lower CD4+ T cell counts (< 200 cells/μL) had lower screening rates than
those who had higher CD4+ T cell counts (Castle et al., 2012; Setse et al., 2012; Kim et al., 2013).
Lack of Adherence
Those who engage in rigorous smoking and drinking habits lacked adherence to cervical
cancer screening among WLWH (Hessol et al., 2013; Fletcher et al., 2014b). Smokers who are of
younger age less likely to adhere to screening tests (Fletcher et al., 2014b). It was very striking to
note that WLWH who engaged in higher amounts of alcohol consumption were five times more
likely to fall into the non-adherence group (Fletcher et al., 2014b).
Studies of urban clinics have demonstrated that non-adherence to the screening tests and
follow-up care was due to low CD4+ T cell counts leading to the progression of lesions, delay in
therapy, and insufficient treatment doses (Lofgren et al., 2015; Levinson et al., 2018). Poor
compliance for attending the screening tests and the follow-up visits was also observed (Curry et
al., 2012; Alade et al., 2017). WLWH without documentation of three or more CD4+ T cell counts
and HIV viral loads along with no evidence of testing for sexually transmitted diseases in the past
year, were less likely to report to have screening tests (Frazier et al., 2016).
Lack of Awareness
Studies demonstrated that there is lack of awareness about cervical cancer as a preventable
disease among WLWH (Cross et al., 2014; Fletcher et al., 2014a). These women reported low
knowledge about the preventive methods such as perceived susceptibility, seriousness about
cervical cancer, barriers to screening methods, benefits, and self-efficacy (Lambert et al., 2015).
Those who had prior atypical cervical cytology were more aware of the Pap tests or HPV tests than
those who had no prior atypical cervical cytology (Cross et al., 2014; Ogunwale et al., 2016).
Limited Transportation Access
Transportation was one of the most persistent barriers for attending appointments to
cervical cancer screening. This is especially relevant for WLWH with longer commutes to the
clinics (Fletcher et al., 2014a).
Pain & Discomfort Associated with Screening Tests
Pain and discomfort caused while receiving the screening tests and with the following
procedures act as barriers for cervical cancer screening in WLWH (Fletcher et al., 2014a). These
women even expressed anxiety associated with undergoing follow-up procedures such as
colposcopies, biopsies, and loop electrosurgical excision procedures (Fletcher et al., 2014a).
Lesser Number of Health Visits
WLWH who had lesser number of health visits were less likely to receive screening tests
than those who had more health visits (Cross et al., 2014; Ogunwale et al., 2016). Cross et al (2014)
demonstrates that WLWH who had a mean of 3.4 visits in a one year of time-period did not receive
screening tests in comparison to those who had a mean of 4.2 visits (p < .01).
Issues related to Gynecological Appointment
Various issues related to gynecological appointments have been described (Fletcher et al.,
2014a). Some WLWH needed a referral from their primary health care provider to see a
gynecologist or a nurse practitioner for receiving the Pap smear screening. These women reported
dissatisfaction for having to make multiple appointments, one for regular health care, one for
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scheduling screening tests, and one for follow-up. Some women reported excessive wait times
associated with making and/or attending additional appointments as a barrier for adherence to
screening tests.
Provider-Specific Barriers
Cross et al. (2014) has listed provider-specific barriers in addition to patient-specific
barriers that affect the cervical cancer screening rates in WLWH at an urban clinic, including that
providers lack training of Pap testing, lack of comfort when performing the test, and were unaware
when patients were due for the Pap tests. It was reported that the procedures are lengthy and timeconsuming, making providers behind schedule, hence, increasing patient wait times.
Lakshmi and colleagues (2018) outlined physician-related barriers such as lack of
awareness of updates on screening guidelines by 21% (n=68). It was also reported that time
allocated for the visits and procedures is not enough (reported by 43%, n=137) and the clinic lacks
electronic system reminders regarding patient’s yearly screening tests (reported by 18%, n=58).
Physicians also reported a lack of availability of support services required for the screening tests.
Other Factors
WLWH sometimes would have to focus on other health priorities rather than getting the
screening tests as reported among 44% (n=142) of the women (Lakshmi et al., 2018). The same
study also reported that 72% (n=232) of study participants declined the screening services
(Lakshmi et al., 2018). Substance use and depression were other factors for not receiving screening
tests in WLWH (Fletcher et al., 2014b; Frazier et al., 2016). Those who had high-risk behaviors
such as intravenous drug use, having unprotected sex or multiple sexual partners were also at risk
of not receiving regular Pap smear tests (Fletcher et al., 2014a). It was also reported that perinatally
infected HIV-adolescents and those who are sexually active had lower screening rates than those
behaviorally infected HIV-adolescents (Setse et al., 2012).
DISCUSSION
Application of the inclusion criteria yielded 21 studies, out of which 17 studies were
eligible for synthesis. This was an acceptable number of pooling considering the time-frame of 5
years (2012-2017) and limiting the studies to the USA population. All relevant research was
included in this systematic review and conclusions were drawn based on the synthesis of available
evidence from relevant studies based on the quality assessment criteria. Studies assessed the
barriers that influence cervical cancer screening rates in WLWH, satisfying the aims and objectives
of this systematic review.
There are several barriers and factors influencing cervical cancer screening rates among
the general population such as older age, lower income, education level, lack of health insurance,
and unmarried status (Datta et al., 2006). The identified perceived barriers for low cervical cancer
screening rates among WLWH through this study include lower level of knowledge of cervical
cancer, multiple sexual partners, HIV status, high viral loads, low CD4+ T cell counts, limited
transportation access, lack of health insurance, lack of a primary health care, pain and discomfort
associated with receiving Pap smears, and issues related to scheduling gynecological
appointments. These women often have poor clinical adherence and challenging social and
financial circumstances.
Facilitators should support to increase the knowledge and awareness regarding cervical
cancer and maintain strong doctor-patient relationships for utilizing cervical cancer screening
services (Fletcher et al., 2014a). One systematic review identified that one on one education was
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useful to increase the awareness about cervical cancer and increase the screening rates by 8%
(Sigrid et al., 2017). Some studies have shown that integration of gynecologic and general medical
care for WLWH is important to patients and is likely to drastically improve screening rates (Oster
et al., 2009; Sigfrid et al., s2017). The combination of automated text messaging and phone call
reminders have been effective to improve the screening rates in the USA as well as in other parts
of the world among WLWH (Mbuagbaw et al., 2015; Ganta et al., 2017). When provided
incentives after undertaking screening tests, patients had positive reinforcement subsequently
improving Pap rates, especially in groups of populations who are affected by poverty (Cross et al.,
2014).
Most results were consistent across different studies and focused on factors that influence
health care in WLWH. Few controversial findings were found between studies. One study reported
lower screening rates when the WLWH were below the federal poverty line, but another study
reported lower screening rates in those who are above the federal poverty line. (Frazier et al., 2016;
Alade et al., 2017). However, the final results should be drawn from the studies based on the
quality.
There are limitations in this systematic review. The methodological quality and risk of bias
assessment was not completed for the cross-sectional studies in this systematic review and may
not show the relevancy of those studies. The systematic review does not include studies from grey
literature such as conference abstracts or unpublished studies, which may miss some relevant
studies identifying the barriers and might have a risk of publication bias. Previous systematic
reviews attempted to identify the barriers cervical cancer screening rates in WLWH, but this
systematic review summarizes the barriers since the implementation of new guidelines in 2012.
The critical appraisal helped to extract and synthesize the outcomes from relevant studies, which
makes this systematic review of high quality. The results synthesized may be generalized to the
WLWH based on the study settings of the studies included, most of the studies are either from a
clinic or a comprehensive HIV-care clinic representing most of HIV care services.
This systematic review represents some of the major barriers for cervical cancer
screening in WLWH. Future studies should address other barriers not discussed in these studies
including trauma, mistrust of the medical community, adverse childhood experiences, intimate
partner violence, and urban vs. rural access to care. Future research should aim at interventions
and public health programs that can decrease these barriers and improve the cervical cancer
screening rates in WLWH.
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